Irinotecan hydrochloride
NDC 16714-131, Irinotecan hydrochloride, injection, from Northstar Rx LLC.
- Product NDC
- 16714-131
- Status
- Listed
- Labeler
- Northstar Rx LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212993
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16714-131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IRINOTECAN HYDROCHLORIDE20 mg/mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16714-131-01 | 16714013101 | 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-131-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4f98e9ed-f7b1-5346-af72-fccb0abf3f4bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=16714-131
Use it
Look up 16714-131 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16714-131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16714-131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.